Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

The landmark Paris Agreement triggered a wave of climate commitments. A decade later, Bloomberg examined seven key categories to chart progress amid a new era of attacks on global warming science and ...

The trading range for stock earnings multiples has shifted higher, quite possibly permanently, says Jim Paulsen ...

In the assessment of 12-month price targets, analysts unveil insights for Palantir Technologies, presenting an average target ...

The U.S. dollar has always been a critical measure of the health of the global economy, but recently this barometer has found ...

BigShort, which officially launched in 2024, is a trading indicator platform designed to give users greater visibility into ...

Crypto miner Cipher Mining (CIFR) soared nearly 20% in pre-market on Monday after announcing a $5.5 billion, 15-year deal ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, ...

In this StockAnalysis Free Newsletter review, I’ll share why this free daily update has quietly become one of the most ...

Overview Artificial Intelligence is transforming trading from rule-based automation to intelligent, data-driven decision-making.ESG integration is turning susta ...

Regulatory measures to rein in retail investor frenzy for options trading begins bearing fruit since they took effect in Nov ...